Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

OncoMed Pharmaceuticals Inc Sees Four Million Share IPO Pricing At $14-$16 Share-DJ


Monday, 8 Jul 2013 06:24am EDT 

Dow Jones reported that OncoMed Pharmaceuticals Inc expects its Initial Public Offering (IPO) of four million common shares to price between $14 and $16 a share. The company first filed plans for an estimated IPO of up to $115 million in May 2012 to fund research and drug discovery activities, working capital and general corporate expenses. The estimated size of the offering is used to set the registration fee and could change materially as the offer progresses. OncoMed has applied to list on the Nasdaq Global Market under the symbol OMED. 

Company Quote

25.89
0.35 +1.37%
27 Mar 2015